Dyne Therapeutics, Inc. ($DYN)
Filing Information
| Accession Number | 0001915598-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 8, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
1,085
Total Value
$25,407.80
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Sep 4, 2026 | Sale | 900 | $24.35 | $21,915.00 | 153,082 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Sep 8, 2026 | Sale | 185 | $18.88 | $3,492.80 | 152,897 | Direct | โ | View Details |